1 October، 2026

screening

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

DGN Gate 29 July، 2024
Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and...
Read More Read more about Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
Savington International Insurance Broker strengthens its regulatory measure and compliance by adopting artificial aided name screening solution from Effiya

Savington International Insurance Broker strengthens its regulatory measure and compliance by adopting artificial aided name screening solution from Effiya

DGN Gate 12 February، 2024
Dubai, United Arab Emirates Savington proudly announces the strategic partnership with Effiya Technologies to fortify its commitment...
Read More Read more about Savington International Insurance Broker strengthens its regulatory measure and compliance by adopting artificial aided name screening solution from Effiya